The Scientist

» clinical trials and neuroscience

Most Recent

image: Does Brain Training Work?

Does Brain Training Work?

By | April 21, 2014

Experts are skeptical about the effectiveness of games that claim to improve cognitive function. 

10 Comments

image: How Artistic Brains Differ

How Artistic Brains Differ

By | April 18, 2014

A study reveals structural differences between the brains of artists and non-artists.

3 Comments

image: Triggering Resilience to Depression

Triggering Resilience to Depression

By | April 17, 2014

In mice, boosting depression-causing activity in neurons can actually reverse depressive symptoms.

4 Comments

image: A Face to Remember

A Face to Remember

By | April 17, 2014

Researchers show that a tuning algorithm can make one’s profile photo more memorable.

5 Comments

image: Sex-Biased Alzheimer’s Variant

Sex-Biased Alzheimer’s Variant

By | April 14, 2014

Women with a notorious variant of a gene involved in Alzheimer’s, APOE4, are much more likely than men with the variant to develop the neurodegenerative disease.

0 Comments

image: Traces of Trauma in Sperm RNA

Traces of Trauma in Sperm RNA

By | April 13, 2014

A mouse study shows that molecular remnants of early-life stress can be passed on to future generations.

3 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Athletes’ Microbiomes Differ from Nonathletes
  3. Gut Feeling
    Daily News Gut Feeling

    Sensory cells of the mouse intestine let the brain know if certain compounds are present by speaking directly to gut neurons via serotonin.

  4. Immune Cells Deliver Cancer Drugs to the Brain
AAAS